-
Entity
-
Individual
-
Location
-
Rigel Pharmaceuticals, Inc., 1180 Veterans Blvd., South San Francisco, CA
-
Summary
-
The estimated net worth of Ryan Maynard is at least $496K dollars as of November 14, 2024. Ryan Maynard is the Director of IOVANCE BIOTHERAPEUTICS, INC. and owns shares of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock worth about $488K. Ryan Maynard is the CHIEF FINANCIAL OFFICER of Cara Therapeutics, Inc. and owns shares of Cara Therapeutics, Inc. (CARA) stock worth about $7.43K.